During the past decade, The Tweed Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 19 clinical trials were completed, i.e. on average, 79.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 14 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Tweed Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Australasian Gastro-Intestinal Trials Group" with 4 trials sponsored, "ETOP IBCSG Partners Foundation" with 3 trials sponsored, "University of Sydney" with 3 trials sponsored and "BeiGene" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Tweed Hospital" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "The Tweed Hospital" are "Breast Cancer" (6 trials), "Breast Neoplasms" (2 trials), "Cancer of the Prostate" (2 trials), "Colorectal Cancer" (2 trials) and "Gastro-Oesophageal Cancer" (2 trials). Many other conditions were trialed in "The Tweed Hospital" in a lesser frequency.

Most popular intervention types in "The Tweed Hospital" are "Drug" (38 trials), "Biological" (6 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (5 trials), "Enzalutamide" (4 trials), "Carboplatin" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Tweed Hospital" are 32 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "The Tweed Hospital". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in The Tweed Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Tweed Hospital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".